Protagonist Therapeutics, Inc. Share Price
Stocks
PTGX
US74366E1029
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
21:00:00 26/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 151.50 USD | +0.60% |
|
-2.22% | +73.46% |
| Market Cap | 9.8B 8.41B 7.9B 7.21B 13.61B 935B 13.68B 93.46B 36.22B 472B 36.81B 36.01B 1,562B | P/E 2026 * |
33x | P/E 2027 * | -300x |
|---|---|---|---|---|---|
| Enterprise Value | 9.27B 7.96B 7.47B 6.82B 12.88B 884B 12.94B 88.4B 34.26B 446B 34.81B 34.06B 1,478B | EV / Sales 2026 * |
17.2x | EV / Sales 2027 * | 46x |
| Free-Float |
97.68% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript : Protagonist Therapeutics, Inc.
| 1 day | +0.60% | ||
| 1 week | -2.22% | ||
| Current month | +10.88% | ||
| 1 month | +11.31% | ||
| 3 months | +51.53% | ||
| 6 months | +71.40% | ||
| Current year | +73.46% |
| 1 week | 147.69 |  | 158.08 |
| 1 month | 130.63 | | 160.81 |
| Current year | 77 | | 160.81 |
| 1 year | 54.5 | | 160.81 |
| 3 years | 13.72 | | 160.81 |
| 5 years | 6.91 | | 160.81 |
| 10 years | 4.47 | | 160.81 |
| Manager | Title | Age | Since |
|---|---|---|---|
Dinesh Patel
CEO | Chief Executive Officer | 69 | 30/11/2008 |
Asif Ali
DFI | Director of Finance/CFO | 52 | 17/04/2022 |
Venkat Thalladi
CTO | Chief Tech/Sci/R&D Officer | - | 31/03/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Dinesh Patel
BRD | Director/Board Member | 69 | 30/11/2008 |
Harold Selick
CHM | Chairman | 71 | 18/03/2014 |
William Waddill
BRD | Director/Board Member | 69 | 30/06/2016 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 11/08/26 | Fiscal year | Chief Executive Officer | 102,717 | 0.1597% | ||
| 10/06/26 | Fiscal year | Director | 27,000 | 0.0420% | ||
| 17/02/26 | Fiscal year | Director | 54,000 | 0.0864% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.60% | -2.22% | +165.84% | +660.54% | 9.8B | |
| -0.31% | +0.17% | +2.52% | +23.41% | 50.96B | |
| +1.92% | +0.36% | +477.97% | +550.09% | 46.18B | |
| -0.15% | -0.28% | +21.65% | +89.41% | 42.73B | |
| +0.81% | +4.91% | +39.28% | +19.41% | 43.04B | |
| -2.27% | -3.02% | +14.22% | +51.50% | 33.48B | |
| +0.81% | +1.77% | +31.91% | +138.26% | 17.28B | |
| -1.08% | -3.61% | - | - | 16.43B | |
| -0.27% | -0.27% | +11.45% | +28.21% | 14.73B | |
| -0.85% | +1.76% | +80.26% | +47.26% | 14.09B | |
| Average | +0.00% | +0.98% | +93.90% | +178.68% | 28.87B | |
| Weighted average by Cap. | +0.17% | +1.04% | +105.65% | +157.63% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 538M 462M 434M 396M 747M 51.33B 751M 5.13B 1.99B 25.9B 2.02B 1.98B 85.77B | 202M 174M 163M 149M 281M 19.3B 282M 1.93B 748M 9.74B 760M 743M 32.25B |
| Net income | 320M 275M 258M 235M 444M 30.52B 446M 3.05B 1.18B 15.4B 1.2B 1.18B 51B | -34.44M -29.56M -27.74M -25.34M -47.82M -3.28B -48.05M -328M -127M -1.66B -129M -127M -5.49B |
| Net Debt | -531M -456M -428M -391M -738M -50.68B -741M -5.07B -1.96B -25.57B -2B -1.95B -84.68B | -503M -432M -405M -370M -699M -47.99B -702M -4.8B -1.86B -24.21B -1.89B -1.85B -80.19B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/08/26 | US$151.50 | +0.60% | 335,462 |
| 25/08/26 | US$150.59 | -2.67% | 664,526 |
| 24/08/26 | US$154.72 | +0.26% | 483,342 |
| 21/08/26 | US$154.32 | +2.41% | 402,542 |
| 20/08/26 | US$150.69 | -2.74% | 518,560 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- PTGX Stock
Select your edition
All financial news and data tailored to specific country editions
